SMILE trial: Difference between revisions
(Added John Peters articles) |
m (fix spelling) |
||
| Line 1: | Line 1: | ||
The '''SMILE Trial''' was a feasibilty study which took place at the Royal National Hospital for Rheumatic Diseases in Bath and the University of Bristol in Britain.<ref name="SMILE, 2013"/> The principle investigator was [[Esther Crawley]]. It was designed to the effects of standard medical treatment (SMC) against that of the [[Lightning Process]] & SMC. The Lightning process takes place over three consecutive days in a group format. Participants were children aged between 12 and 18 drawn from the Bristol and Bath areas.<ref>[http://www.bristol.ac.uk/media-library/sites/ccah/migrated/documents/protocol1.pdf SMILE Trial Protocol - Bristol University 2013]</ref> Those who were housebound were excluded. | The '''SMILE Trial''' was a feasibilty study which took place at the Royal National Hospital for Rheumatic Diseases in Bath and the University of Bristol in Britain.<ref name="SMILE, 2013"/> The principle investigator was [[Esther Crawley]]. It was designed to the effects of standard medical treatment (SMC) against that of the [[Lightning Process]] & SMC. The Lightning process takes place over three consecutive days in a group format. Participants were children aged between 12 and 18 drawn from the Bristol and Bath areas.<ref>[http://www.bristol.ac.uk/media-library/sites/ccah/migrated/documents/protocol1.pdf SMILE Trial Protocol - Bristol University 2013]</ref> Those who were housebound were excluded. | ||
The co-applicant for the study was Fiona Finch, the Research Director at the | The co-applicant for the study was Fiona Finch, the Research Director at the Lightning Process company (Phil Parker Ltd). | ||
== Methodology == | == Methodology == | ||
| Line 21: | Line 21: | ||
The results have been not published in paper despite the trial being completed in 2013. There has been no further study following on from this feasibility one. | The results have been not published in paper despite the trial being completed in 2013. There has been no further study following on from this feasibility one. | ||
There are some selective quotes in a 2015 paper<ref>[http://adc.bmj.com/content/100/12/1141.abstract What matters to children with CFS/ME? A conceptual model as the first stage in developing a PROM - Archives of Disease in Childhood, Crawley et al 2015]</ref> as well the final study protocol, which was | There are some selective quotes in a 2015 paper<ref>[http://adc.bmj.com/content/100/12/1141.abstract What matters to children with CFS/ME? A conceptual model as the first stage in developing a PROM - Archives of Disease in Childhood, Crawley et al 2015]</ref> as well the final study protocol, which was published after the trial ended. James Coyne said of the quotes "(they) cannot be independently evaluated. Readers are not told how representative these quotes, the outcomes for the children being quoted or the overall outcomes of the trial." <ref>[http://blogs.plos.org/mindthebrain/2016/09/23/before-you-enroll-your-child-in-the-magenta-chronic-fatigue-syndrome-study-issues-to-be-considered/ Before you enroll your child in the MAGENTA chronic fatigue syndrome study: Issues to be considered - James Coyne (September 2015) Plos Blog]</ref> | ||
==Investigators== | ==Investigators== | ||
Revision as of 00:58, July 21, 2017
The SMILE Trial was a feasibilty study which took place at the Royal National Hospital for Rheumatic Diseases in Bath and the University of Bristol in Britain.[1] The principle investigator was Esther Crawley. It was designed to the effects of standard medical treatment (SMC) against that of the Lightning Process & SMC. The Lightning process takes place over three consecutive days in a group format. Participants were children aged between 12 and 18 drawn from the Bristol and Bath areas.[2] Those who were housebound were excluded.
The co-applicant for the study was Fiona Finch, the Research Director at the Lightning Process company (Phil Parker Ltd).
Methodology[edit | edit source]
The trial compared patients receiving Standard Medical Care (SMC) against the Lightning Process (LP) in conjunction with SMC.
Outcome was initially to be based on school attendance.[3] This was changed to assessment based on the following scales: the Chalder fatigue scale, pain visual analogue scale,[4] physical function short form (SF-36), the Spence Children’s Anxiety Scale (SCAS),[5][6] the Hospital Anxiety and Depression Scale (HADS) for children aged 14 and over,[7][8] and the Euroqol (EQ-5D),[9] a five-item quality of life inventory.
Out of 156 children considered eligible, 56 participated, with the study beginning in September 2012. Anxious children were offered 3 sessions of CBT over a 6 week period.
SMC was graded activity with phone calls and family based rehabilitation consultations lasting an hour at 6 weeks, 3 months & 4.5 months.
Funding[edit | edit source]
The initial budget was £164,000 funded by the Linbury Trust and the Ashden Trust.[10]
Research Ethics[edit | edit source]
Results[edit | edit source]
The results have been not published in paper despite the trial being completed in 2013. There has been no further study following on from this feasibility one.
There are some selective quotes in a 2015 paper[11] as well the final study protocol, which was published after the trial ended. James Coyne said of the quotes "(they) cannot be independently evaluated. Readers are not told how representative these quotes, the outcomes for the children being quoted or the overall outcomes of the trial." [12]
Investigators[edit | edit source]
Esther Crawley, Nicola Mills, Will Hollingworth, Zuzana Deans, Jonathan A Sterne, Jenny L Donovan, Lucy Beasant and Alan Montgomery
Criticisms[edit | edit source]
- John Peters has criticised the study.[13][14][15]
See also[edit | edit source]
References[edit | edit source]
- ↑ Crawley, Esther; Mills, Nicola; Beasant, Lucy; Johnson, Debbie; Collin, Simon M; Deans, Zuzana; White, Kate; Montgomery, Alan (2013), "The feasibility and acceptability of conducting a trial of specialist medical care and the Lightning Process in children with chronic fatigue syndrome: feasibility randomized controlled trial (SMILE study)", Trials, 14 (415), doi:10.1186/1745-6215-14-415
- ↑ SMILE Trial Protocol - Bristol University 2013
- ↑ Final Study Protocol - Crawley et al (Dec 2013)
- ↑ Viusal Analogue Scale - Physiopedia
- ↑ Self completed questionnaires were completed at the first clinical assessment and subsequently at 6 weeks, 3 months, 4.5 months Wikipedia - Spence Children's Anxiety Scale
- ↑ Example of Spence Children's Anxiety Scale - Psychology Tools
- ↑ Wikipedia - Hospital Anxiety and Depression Scale
- ↑ Example of HADS questionnaire - Scales and Measures
- ↑ Wikipedia - EQ-5D
- ↑ £164,000 grant for study into the Lightning Process and children with ME - ME Association (March 2010)
- ↑ What matters to children with CFS/ME? A conceptual model as the first stage in developing a PROM - Archives of Disease in Childhood, Crawley et al 2015
- ↑ Before you enroll your child in the MAGENTA chronic fatigue syndrome study: Issues to be considered - James Coyne (September 2015) Plos Blog
- ↑ THE SMILE TRIAL (part 1)
- ↑ THE SMILE TRIAL (part 2)
- ↑ THE SMILE TRIAL (part 3)
